Hepatitis E is inflammation of the liver resulting from infection with the hepatitis E virus (HEV), recognized as the fifth form of viral hepatitis [1][2]. The virus is excreted in stool and enters the body through the oral route [1].
Disease overview
Hepatitis E is a liver inflammation caused by the hepatitis E virus and represents one of the most frequent causes of acute viral hepatitis globally [1][2]. An estimated 20 million people are infected each year worldwide [3]. The illness is usually self-limiting, though severe acute liver failure can occasionally prove fatal [1].
Read the full clinical and epidemiological profile 6
The incubation period after exposure ranges from 2 to 10 weeks, averaging 5 to 6 weeks, and viral shedding begins a few days before to several weeks after symptom onset [1][2]. Most infections are asymptomatic with spontaneous viral clearance, but a self-limiting hepatitis may occur and occasionally progresses to fulminant hepatitis or acute liver failure [1][3]. In endemic areas, symptomatic disease is most common among young adults aged 15–40 years, while children often have mild or silent illness [1].
Hepatitis E occurs worldwide and is especially common in low- and middle-income countries with poor water, sanitation, and hygiene services, appearing as both outbreaks and sporadic cases [1][2]. HEV genotypes 1 and 2 predominate in developing regions and drive large waterborne outbreaks, whereas genotypes 3 and 4 are encountered mainly in developed countries with zoonotic transmission [1][2][3]. Approximately 20 million infections occur annually, and in high-endemicity settings symptomatic infection concentrates in young adults [1][3]. Outbreaks have affected conflict and humanitarian emergency settings where safe water is limited [1].
HEV is shed in feces and primarily enters humans via the oral route, mainly through contaminated drinking water in a fecal–oral manner [1]. Genotypes 1 and 2 spread chiefly among humans through contaminated water, while genotypes 3 and 4 are mainly zoonotic, transmitted by consumption of undercooked meat and likely environmental exposure [1][2][3].
Prevention of hepatitis E centers on avoiding transmission routes identified in the evidence. Since genotypes 1 and 2 are mainly faecal-orally transmitted via contaminated drinking water, especially in low- and middle-income countries with limited water, sanitation and hygiene access, ensuring safe water and sanitation is critical [1]. Genotypes 3 and 4 are mainly zoonotic, transmitted through consumption of uncooked or undercooked meat, indicating that proper cooking of meat is a relevant preventive measure [1]. For outbreak response, a hepatitis E vaccine was approved under the International Coordinating Group mechanism and WHO is working to make it available as an outbreak response intervention; WHO also issued guidance in 2014 on recognition, investigation and control of waterborne outbreaks [1].
- 1 World Health Organization. Hepatitis E [Internet]. cited 3 Sept 2026. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e
- 2 Aslan AT et al. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol. 2020 Oct 7. PMID: 33071523. doi: 10.3748/wjg.v26.i37.5543. PubMed: https://pubmed.ncbi.nlm.nih.gov/33071523/
- 3 Songtanin B et al. Hepatitis E Virus Infections: Epidemiology, Genetic Diversity, and Clinical Considerations. Viruses. 2023 Jun 17. PMID: 37376687. doi: 10.3390/v15061389. PubMed: https://pubmed.ncbi.nlm.nih.gov/37376687/
- B17.2
- 1E50.4
Loading current data…
Country surveillance trends
Choose a country, source, and measure. Each line retains its published reporting period and definition.
Coverage
Reporting countries and regions
The map shows reporting coverage. Select a measure or open a shaded location to inspect its data.
Loading current data…
Surveillance pattern
Year × month seasonality by country
Review one country’s published monthly values by year. Empty cells indicate values the source did not publish.
Research Radar
Recent related research
Hepatitis E virus genome plasticity: a marker of chronicity and therapy failure?
Communications Biology
Virus-specific T cells and neutralizing antibodies are independent correlates of long-term protective immunity against hepatitis C virus
Journal of Virology
Enhanced detection of occult and active infections using multiplex HIV/HBV/HCV nucleic acid testing in high-risk populations: a cross-sectional study
Frontiers in Cellular and Infection Microbiology
Estimating new viral hepatitis infections from reported acute cases in the United States
Open Forum Infectious Diseases
A novel biomarker signature based on circulating transfer RNA (tRNA) can detect and differentiate HIV-2 infection from HIV-1
Journal of Clinical Microbiology
Showing 5 of 99 related publications.
Literature links are provided for discovery and do not alter or validate the surveillance series above.
Loading official alerts…
Downloads and methods
Choose a time range and download CSV, JSON or XLSX files.

